pulmonary defense mechanisms
TRANSCRIPT
![Page 1: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/1.jpg)
PULMONARY DEFENSE MECHANISMS
Dr. Dalia Abdallah El-ShafeiLecturer, Community medicine department, Zagazig
University
![Page 2: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/2.jpg)
PARTICLES
![Page 3: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/3.jpg)
Inhalable particles are small droplets or solids -
organic or inorganic, viable or nonviable- that
can become airborne and penetrate into the
oral or nasal airways.
![Page 4: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/4.jpg)
FACTORS AFFECTING PARTICLES’
EFFECTS:
Diameter
Shape
Density
Composition
Concentration
Dimensions of Air passages
Pattern of air flow
![Page 5: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/5.jpg)
DIAMETER
Spherical particles:
Mass median diameter (depend on physical
diameter & density)
Non-spherical particles:
Aerodynamic diameter (depend on
aerodynamic drag)
![Page 6: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/6.jpg)
A particle falling through the air under the force of gravity
(gravitational sedimentation) accelerates until it reaches a
velocity at which the force of gravity is just balanced by the
viscous resistive force exerted by the air (Stokes' law). This
velocity is known as the terminal settling velocity.
Thus, the aerodynamic diameter of a particle, however shaped,
is taken as the diameter of a unit density sphere that would
have the identical terminal settling (Stokes) velocity.
AERODYNAMIC DIAMETER
![Page 7: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/7.jpg)
AEROSOL SIZE DEFINITION
Inhalable
• >100µm
Thoracic
• >10µm
Respirable
• >5µm
![Page 8: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/8.jpg)
EPA PARTICULATE MATTER (PM)
Total PM
TPM
(Supercoarse)
>10µm
Coarse PM
PM10
2.5-10µm
Fine PM
PM2.5
•1-2.5µm
Ultrafine PM
<1µm
![Page 9: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/9.jpg)
![Page 10: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/10.jpg)
SHAPE
Fibrous
(length : diameter) = (3:1)
![Page 11: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/11.jpg)
PATTERN OF AIR FLOW
Slow deep breathing:
↑ sedimentation in all RT.
Rapid shallow breathing:
↑ impaction in LAWs (mainly in “hot spot”
around bifurcation angle) & sedimentation in
SAWs.
![Page 12: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/12.jpg)
PARTICLES DEPOSITION PROCESSES
![Page 13: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/13.jpg)
![Page 14: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/14.jpg)
Perfect Lung
Mechanisms of deposition of aerosol
![Page 15: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/15.jpg)
![Page 16: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/16.jpg)
IMPACTION
Particles with sufficient mass will strike withresp.epith.surface at points of branching andcurvature “Hot spots”
As direction of air velocity change, particles’inertial force will prevent them fromchanging directions at rate as that of air flow.
The greater the mass, the less ability ofparticles to change direction with air flow.
![Page 17: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/17.jpg)
SEDIMENTATION
Particles which are of sufficiently small size to
escape deposition by inertia, may deposit on
resp.epith. Through sedimentation when velocity
of air flow become slow.
Gravity is the predominant force.
Sedimentation rate α particle density.
Sedimentation rate α (particle diameter)²
![Page 18: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/18.jpg)
DIFFUSION
For extremely small particles “Brownian
motion” in which suspended particles
bombarded by surrounding gaseous
molecules.
Rate of diffusion inversely proportionate to
particle diameter.
![Page 19: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/19.jpg)
LUNG DEFENSE MECHANISMS
![Page 20: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/20.jpg)
Upper airway filter
Lower airway filter
Macrophage clearance to
airways
Macrophageclearance via lymphatics
![Page 21: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/21.jpg)
![Page 22: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/22.jpg)
![Page 23: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/23.jpg)
UPPER AIRWAY FILTER
Hairs & mucosal folds over turbinate direct
airflow through nose so most particles > 15 µm
diameter, hit surface and carried in mucus to
pharynx then swallowed.
If particles are irritant or allergic→ running
eyes &nose + sneezing.
At work a certain tolerance may develop.
Heavy work or nasal obstruction → mouth
breath → bypass UAW filter
![Page 24: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/24.jpg)
LOWER AIRWAY FILTER
Mucociliary epithelial lining (goblet cells,
submucosal seromucus glands) act as a low
resistance filter, which remove nearly all
particles down to 5 µm.
Particles carried in the mucus (viscoelastic)
back to larynx, joining particles from UAW.
200 cilia per cell, each beat 1000 times/min in
a wave-like pattern.
![Page 25: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/25.jpg)
![Page 26: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/26.jpg)
Mucociliary escalator
![Page 27: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/27.jpg)
Goblet Cell
![Page 28: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/28.jpg)
Ciliary action
![Page 29: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/29.jpg)
Cilia just touching the gel layer
![Page 30: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/30.jpg)
Gel layer of the mucus above the sol layer
![Page 31: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/31.jpg)
Irritants → + nerve endings
→ Cough + Airway
narrowing + Outpouring of
secretions. → prolonged
exposure → goblet cell
proliferation + submucosal
gland hypertrophy →
Chronic bronchitis.
![Page 32: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/32.jpg)
Normal airway (above); Enlarged mucous glands (below)
![Page 33: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/33.jpg)
IMPAIRMENT OF NORMAL MUCOCILIARY
FUNCTION
Mucus: too much, or change in composition, e.g.
chronic bronchitis, cystic fibrosis, asthma
Cilia: paralysis by toxic gases
bronchial epithelium destroyed
congenital defect of ciliary motion
![Page 34: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/34.jpg)
MACROPHAGE CLEARANCE TO AIRWAYS
Particles getting beyond mucociliary clearancecalled “Respirable or Alveolar dust”
Very small particles (<0.5 µm) sediment so slowly→ + type II cells → surfactant → coat particles.
Macrophages move out from wall →engulf coatedparticles → some moving back in when fullyloaded →many of dust particles dissolve bylysosomal enzymes → when they are fully ladenwith insoluble material →migrate throughinterstitium to centers of lobules →enter mucus-lined airways →carried by mucus to larynx withrest of dust.
![Page 35: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/35.jpg)
By this mechanisms, lungs can clear most
retained dusts as results of regular exposure
at work up to 4mg/m³ of respirable particles
provided that macrophages not damaged.
Above this level →system become
overloaded →dust accumulate in lung
![Page 36: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/36.jpg)
IMPAIRMENT OF NORMAL MACROPHAGE
FUNCTION
Inhaled gases (ozone, cigarette smoke)
Toxic particles (silica)
Alveolar hypoxia
Radiation
Corticosteroids
Alcohol ingestion
![Page 37: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/37.jpg)
ALVEOLAR MACROPHAGE
![Page 38: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/38.jpg)
Alveolar macrophage in the corner of an alveolus
![Page 39: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/39.jpg)
MACROPHAGE CLEARANCE VIA LYMPHATICS
Failure of dust clearance usually a result ofcombination of dust (overload + property) →damage macrophages → cell die → dustpicked up by other macrophages whichattempt to carry it to Hilar LNs via lymphatics(inter lobular septa & under pleura)
Dust can get struck along either route or inhilar LNs
Some carried on into blood stream to spleen,BM, or kupffer cells in liver, and soaccumulate in body.
![Page 40: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/40.jpg)
Clearance of deposited particles
![Page 41: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/41.jpg)
LUNG IMMUNE DEFENSES AGAINST
ENVIRONMENTAL AGENTS
![Page 42: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/42.jpg)
PATHOGENS
Pathogens enter the airways from two major
sources:
Inhalation of bioaerosols in the environment
Aspiration of nasopharyngeal secretions.
![Page 43: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/43.jpg)
![Page 44: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/44.jpg)
AntimicrobialComponents
Lysozyme & Lactoferrin
SLPI
surfactant
Antibodies & Complement
IgA,IgG
Antioxidants
Immune cells
![Page 45: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/45.jpg)
ANTIMICROBIAL COMPONENTS
Two of the most abundant antimicrobial
proteins of airway secretions are:
Lysozyme & Lactoferrin (0.1 - 1 mg/ml).
Secretory leukoprotease inhibitor (SLPI)
surfactant
![Page 46: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/46.jpg)
Lysozyme:
- Enzymatic lysis of bacterial cell walls, can also kill
bacteria non-enzymatically.
- Highly active against many Gram +ve species but
is relatively ineffective against Gram -ve bacteria.
- Produced by both epithelial cells & leukocytes.
- It is about 10-fold more abundant in the initial
"airway" aliquot than in later samples of BAL.
![Page 47: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/47.jpg)
Lactoferrin:
- Iron-binding protein highly abundant in the specific
granules of human neutrophils & epithelial
secretions.
- Inhibits microbial respiration & growth, by
sequestering essential iron.
- Can also be directly microbicidal.
![Page 48: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/48.jpg)
Secretory leukoprotease inhibitor (SLPI)
- Antimicrobial activity against in vitro Gram - ve
& +ve bacteria.
![Page 49: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/49.jpg)
Surfactant
- At the alveolar level, there are 2 components of the
surfactant layer: Surfactant proteins A & D.
- Bind to microorganisms & enhance adhesion &
phagocytosis of microorganisms by agglutination
& opsonization.
- Also directly antimicrobial.
![Page 50: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/50.jpg)
![Page 51: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/51.jpg)
![Page 52: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/52.jpg)
ANTIBODIES AND COMPLEMENT
Potent immune system molecules present in airway& alveolar lining fluid.
Mainly immunoglobulin A (IgA) & G (IgG).
IgA “UAW” is predominantly found along the nasopharyngeal mucosa & in large airway; its
relative concentration decreases progressively from larger to smaller airways.
IgG “LAW” is the major antibody found in alveolar fluid.
![Page 53: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/53.jpg)
ANTIOXIDANTS
The first line of defense against inhaled oxidant
gases (& particles) “O3 & NO2”, normally present
in lung lining fluid.
Glutathione & Ascorbate, Uric acid, & α-
tocopherol.
Achieving toxicity through intermediates formed
when antioxidant defenses are overwhelmed.
![Page 54: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/54.jpg)
![Page 55: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/55.jpg)
SURVEILLANCE BY CELLULAR FIRST
RESPONDERS
Macrophages
Include subsets in distinct anatomic compartments(Alveolar, interstitial, & airway macrophages).
The most numerous & well studied is alveolarmacrophage (AM). Normal adult lungs contain about20*109 Ams (BAL routinely yields 10 to 20*106 ).
AMs are ultimately derived from BM hematopoiesis.
Injury → influx & differentiation of blood monocytes→ Increases in macrophage number.
Life span of AMs in normal individuals range fromone to several months.
![Page 56: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/56.jpg)
The main function of the AM is phagocytosis &
clearance of inhaled material.
The AMs can ingest, but fail to kill, certain
microorganisms, as (Mycobacterium, Nocardia &
Legionella) which are then capable of replicating
intracellularly. Ultimate eradication of these
pathogens requires the development of CMI.
![Page 57: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/57.jpg)
The process of phagocytosis:
1- Recognition or binding of phagocytic targets.
- AMs possess a broad array of membrane
receptors that mediate binding of organisms and
particles.
- Phagocytosis is initiated by these specific
receptors that either recognize serum components
(opsonins) (opsonin-dependent) or directly
recognize molecular determinants on the
target(opsonin-independent).
![Page 58: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/58.jpg)
2- Internalization & killing:
AM has considerable microbicidal machinery.
Generates Reactive Oxygen Species (ROS)
(using the "respiratory burst") that contribute to
pathogen killing.
Reactive Nitrogen Intermediates (RNI) can also
contribute to pathogen killing.
![Page 59: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/59.jpg)
3- Movement of AMs to the Mucociliary escalator:
After ingestion of particles, AM functions
ultimately to remove offending material from lung.
Movement of AMs to the mucociliary escalator &
clearance to the oropharynx.
Entry of macrophages into tissue compartments,
lymphatics & migration to thoracic lymph nodes.
![Page 60: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/60.jpg)
4- Release of inflammatory mediators
Include lipid mediators (e.g., LTB4) &
chemokines (interleukin-8).
AM recruit additional help {polymorphonuclear
neutrophils (PMNs)}.
![Page 61: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/61.jpg)
![Page 62: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/62.jpg)
Ciliated Epithelial Cells
Integral part of the mucociliary clearance system.
Produce important components of the lining fluid inairway & alveolus {Mucus, Surfactant,Complement, Lysozyme}.
Some direct antibacterial function.
Secrete a large array of cytokines & othermolecules (e.g., IL-1, -5, -6, -8, GM-CSF) whichchemoattract & activate cells of the innate &adaptive immune system, which, in turn,immobilize and kill microorganisms.
![Page 63: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/63.jpg)
Polymorphonuclear Neutrophils
- The major 2nd cellular defense.
- Up to 40% of blood PMNs are marginated or intransit through the lung, facilitating recruitment whenneeded.
- Rapid & large movement of PMNs into the alveoli isachieved by influence of several chemotactic factorsreleased by AMs & other lung cells (e.g., IL-8,leukotrienes, complement fragments).
- Killing of ingested microorganisms by generation ofNADPH oxidase-dependent ROS (e.g., superoxide,hydrogen peroxide) & by phagolysosomal fusion.
![Page 64: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/64.jpg)
Mast Cells
In intraepithelial locations or around blood vessels
& bronchioles.
Produce Tumor Necrosis Factor (TNF) & a wide
range of cytokines & chemokines & important lipid
mediators, such as LTC4 and LTB4.
![Page 65: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/65.jpg)
Natural Killer Cells (NK)
Arise from same hematopoietic lineage as T cells, (Butnot mature in thymus & not express re-arrangedantigen receptors).
Important in initial defenses against viral infection oflungs. Local release of IL-12 & IL-15 by dendriticcells & macrophages contributes to stimulation of NKcells.
Recognize virus-infected (& neoplastic) cells becauseof their altered expression of leukocyte antigen (HLA)class I tissue antigens.
Release Interferon-γ (IFN- γ), which, in turn, leads torecruitment of other immune cells.
![Page 66: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/66.jpg)
![Page 67: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/67.jpg)
Dendritic Cells (DCs)
Characteristic long, branched processes. In airways,
alveolar parenchyma, and thoracic lymph nodes.
Specialized mononuclear phagocytes with important
functions in antigen presentation & initiation of adaptive
immune responses.
![Page 68: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/68.jpg)
Acting as sentinels in airways, they sample incomingpathogens and antigens through by phagocytosis.When this is accompanied by a second, "danger"signal, they undergo a phenotypic & functional changefrom their basal immature state.
This maturation promotes the processing of antigenand its presentation on the cell surface and themigration of the dendritic cell to T-cell rich areas ofnearby lymph nodes. Here they can initiate or amplifyadaptive immune responses by triggering proliferationand activation of antigen-specific T lymphocytes.
![Page 69: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/69.jpg)
![Page 70: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/70.jpg)
CYTOKINES
Critical for successful orchestration of defense
mechanisms against environmental agents & are
also mediators of untoward outcomes such as
acute injury & chronic inflammation & fibrosis.
TNF & chemokines which function in both acute
and chronic phases of these processes.
![Page 71: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/71.jpg)
Tumor Necrosis Factor
TNF- αis a protein.
Monocytes express at least 5 different molecular forms of TNF-α.
Macrophages are considered the most prolific sources.
lymphoid cells, mast cells, endothelial cells, fibroblasts, and neuronal tissue.
Two types of TNF receptors, TNF-R1 & TNF-R2, are present on virtually all cells except RBCs.
Present during acute response to acute inflammatory responses to toxic environmental agents{silica, asbestos, air pollution particles,
welding fumes, ozone}.
![Page 72: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/72.jpg)
Chemokines
Plays a critical role in this process of recruitment
& maintenance of inflammatory cells in the lungs
after environmental exposures.
Produced by Ams, monocytes, neutrophils, T & B
lymphocytes, NK cells, epithelial cells,
fibroblasts, smooth muscle cells, mesothelial
cells, and endothelial cells.
![Page 73: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/73.jpg)
ADAPTIVE IMMUNITY
The adaptive immune response to pulmonary
pathogens includes (humoral & cellular components).
Both B & T lymphocytes are present in normal lung.
B cells are predominantly found in airway lymphoid
aggregates, where they outnumber the T cells.
In normal lavage samples, approximately 5-10% of
cells are lymphocytes, which, in turn, can be further
divided into functionally important subsets, for
example, CD4+ T helpers & CD8+ cytotoxic T cells.
![Page 74: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/74.jpg)
![Page 75: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/75.jpg)
GRANULOMATOUS INFLAMMATION
![Page 76: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/76.jpg)
In response to certain infectious agents & persistentforeign material, & as part of a disease of unknownetiology (e.g., sarcoidosis).
Chronic inflammation, dominated by mononuclearphagocytes “macrophages, epithelioid cells, &multinucleated giant cells”.
Typically, these cells congregate & form well-demarcated focal lesions called granulomas.
Admixture of other cells,(lymphocytes, plasma cells,& fibroblasts).
Granuloma formation typically ends in fibrosis.Fibrosis serves to wall off the granuloma contents andlimit spread of infection and organ damage.
![Page 77: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/77.jpg)
![Page 78: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/78.jpg)
![Page 79: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/79.jpg)
![Page 80: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/80.jpg)
![Page 81: Pulmonary defense mechanisms](https://reader037.vdocuments.site/reader037/viewer/2022103117/55a724dc1a28ab00188b47ee/html5/thumbnails/81.jpg)